Teva Pharma (TEVA) Needs to Raise Mylan (MYL) Bid to $85-$88/Share, Leerink Partners Says

April 21, 2015 12:10 PM

Leerink Partners analyst Jason Gerberry weighed on Teva Pharma (NYSE: TEVA) after the company announced an unsolicited $82/share offer for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found